Market Place
Sourcing Support
All News #Library
Biotech
Ovid Pharma Hosts KCC2 R&D Deep Dive on April 14
08 Apr 2026 //
GLOBENEWSWIRE
Ovid Therapeutics Announces OV329 Data, OV4071 Clearance
18 Mar 2026 //
GLOBENEWSWIRE
Ovid Therapeutics To Participate In Upcoming Investor Conferences
25 Feb 2026 //
GLOBENEWSWIRE
Ovid Therapeutics Reports Phase 1 Data for OV350 KCC2
18 Dec 2025 //
GLOBENEWSWIRE
Ovid Reports Strong Result of Inhibitory Activity Of OV329
03 Oct 2025 //
GLOBENEWSWIRE
Ovid Therapeutics Prices Private Placement Raising $175M
03 Oct 2025 //
GLOBENEWSWIRE
Ovid Therapeutics Joins BTIG Virtual Biotech Conference
23 Jul 2025 //
GLOBENEWSWIRE
Ovid pauses ph. 2 plans for ROCK2 inhibitor to mull rival`s data
13 Nov 2024 //
FIERCE BIOTECH
Ovid Therapeutics Presents Pre-Clinical Results On OV329
26 Sep 2024 //
GLOBENEWSWIRE
Ovid Therapeutics Appoints Dr Amanda Banks As Chief Development Officer
08 Aug 2024 //
GLOBENEWSWIRE
Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit
10 Oct 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.